SCHEMBL6978232

SCHEMBL6978232

O=c1ccn2c3ccc(Br)cc3c3cc(O)cc1c32

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 1/20 0.36
ABCC2 Q92887 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
CYP1A2 P05177 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
DNMT1 P26358 1/20 0.33
TP53 P04637 1/20 0.33
PIM1 P11309 1/20 0.33
GABRP O00591 1/20 0.32
GABRD O14764 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRB1 P18505 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA5 P31644 1/20 0.32
GABRA3 P34903 1/20 0.32
GABRA2 P47869 1/20 0.32
GABRB2 P47870 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7971630 0.88 EGLN1 (0.33) CHEK1TP53ESR1ESR2
SCHEMBL8152607 0.85 LMNA (0.36) SMN1; SMN2TP53MAPTLMNAHTT
SCHEMBL6982438 0.82 PIK3R1 (0.39) SMN1; SMN2GABRPGABRDGABRA1GABRB1
SCHEMBL8157626 0.80 POLB (0.36) SMN1; SMN2DNMT1TP53MAPTLMNA
SCHEMBL6983135 0.79 PTGDR2 (0.39) DNMT1MEN1KMT2A
SCHEMBL7083107 0.78 IDO1 (0.33) MAPTLMNASIGMAR1
SCHEMBL8157787 0.78 MAOB (0.44) CHEK1SMN1; SMN2HTTMEN1KMT2A
SCHEMBL6981368 0.77 LMNA (0.38) ABCC2SMN1; SMN2CYP1A2MAPTESR2
SCHEMBL6979976 0.75 SMN1; SMN2 (0.34) SMN1; SMN2MAPTLMNAHTTNPSR1
SCHEMBL7087746 0.74 MAOA (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0985671-B1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARM CO LTD (JP) 2003-04-02 EP disclosed
US-6197768-B1 THERAPY, PREVENTION ISCHEMIC HEART DISEASE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2001-03-06 US disclosed
EP-0992240-A1 THERAPEUTIC AGENT FOR ERECTION FAILURE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-04-12 EP disclosed
EP-0985671-A1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-03-15 EP disclosed
US-6018046-A SELECTIVE ACTION IN INHIBITING CYCLIC GMP-PHOSPHODIESTERASE (CGMP-PDE); PHARMACEUTICALS FOR TREATING DISEASES AGAINST WHICH THE INHIBITORY ACTION IS EFFECTIVE, SUCH AS PULMONARY HYPERTENSION MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-01-25 US disclosed